First Australian patients with coronavirus to get remdesivir
Two hospitals, including Dr James McMahon's The Alfred, have so far been approved to use the antiviral hailed in the US as the likely standard of care
Critically ill patients with COVID-19 in Sydney and Melbourne will be among the first Australians to be treated with the experimental antiviral remdesivir.
Manufacturer Gilead Sciences Australia says two hospitals have been given special access to its drug as part of a global program.
